How Much Does Armour Thyroid Cost in Delaware in 2026?

Delaware Cash-Pay Pricing for Armour Thyroid in 2026

The average retail cash price for Armour Thyroid across Delaware pharmacies sits at roughly $85 per month in 2026. That figure represents a significant discount from the $180 Allergan list price, driven by pharmacy-level pricing competition and discount card programs. Prices can swing by $20 to $30 depending on the specific pharmacy chain and location within the state.

Armour Thyroid (thyroid desiccated) is a porcine-derived combination of T4 (levothyroxine) and T3 (liothyronine) that has been used for hypothyroidism treatment since before the modern FDA approval framework existed [1]. The FDA-approved labeling lists its indication for hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. Because no AB-rated generic exists, brand pricing remains higher than synthetic levothyroxine alternatives. A 2013 randomized crossover trial by Hoang et al. (N=70) found that 48.6% of patients preferred desiccated thyroid extract over levothyroxine, with modest weight loss of 2.86 lb (P = 0.02) favoring the desiccated product [2]. This preference data helps explain why patients seek affordable access to Armour Thyroid specifically, despite cheaper synthetic options.

Pharmacy discount platforms such as GoodRx and RxSaver can lower the cash price at certain Delaware locations to between $60 and $75 for a 30-day supply, depending on dose strength. Always confirm the specific NDC and quantity when comparing prices, as per-tablet costs vary across the 15 mg through 300 mg tablet range.

Delaware Medicaid Coverage for Armour Thyroid

Delaware Medicaid does cover Armour Thyroid, but patients need prior authorization (PA) before the state program will pay. The PA process typically requires documentation that the patient has tried and failed synthetic levothyroxine, or that a clinician has provided a medical rationale for combination T4/T3 therapy.

The American Thyroid Association (ATA) 2014 guidelines acknowledge that a trial of combination T4/T3 therapy may be considered in hypothyroid patients who have persistent symptoms despite adequate levothyroxine dosing and normal TSH levels [3]. This guideline language supports PA requests. Delaware Medicaid formulary decisions align with federal Medicaid requirements under the Omnibus Budget Reconciliation Act of 1990, which mandates that state programs cover all FDA-approved drugs from manufacturers with rebate agreements, provided utilization management criteria are met [4].

To initiate a PA, prescribers submit a form through the Delaware Division of Medicaid and Medical Assistance (DMMA). Approval timelines run 24 to 72 hours for standard requests. Urgent requests may receive same-day review. If the initial PA is denied, patients can appeal through a fair hearing process. A prescriber letter citing the ATA guidelines and documenting prior levothyroxine trial strengthens the appeal significantly.

According to the 2023 ATA presidential address published in Thyroid, approximately 10% to 15% of hypothyroid patients on levothyroxine monotherapy report residual symptoms despite biochemically normal TSH, providing a clinical basis for alternative formulations [5].

Compounded Natural Desiccated Thyroid in Delaware

Compounded natural desiccated thyroid is legal and available in Delaware through licensed 503A compounding pharmacies. The average cost is roughly $40 per month, making it the cheapest NDT option in the state.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound drugs for individual patients based on valid prescriptions [6]. Delaware's Board of Pharmacy regulates these pharmacies under Title 24, Chapter 25 of the Delaware Code. Compounded NDT is prepared from thyroid powder USP, which contains a standardized ratio of approximately 38 mcg T4 and 9 mcg T3 per grain (65 mg).

A key distinction: compounded NDT does not undergo the same batch-to-batch potency testing as commercial Armour Thyroid. The FDA's 2023 guidance on compounding emphasizes that compounded products are not FDA-approved and do not carry the same assurance of potency, purity, or stability [7]. Patients switching from Armour Thyroid to compounded NDT should have TSH and free T4 checked 6 to 8 weeks after the transition to confirm therapeutic equivalence.

Several Delaware compounding pharmacies offer NDT in capsule form, which allows for dose customization beyond the fixed tablet strengths available with Armour Thyroid. This flexibility can be useful for patients requiring doses between standard increments, such as 45 mg or 97.5 mg.

Insurance Coverage Beyond Medicaid

Commercial insurance plans in Delaware vary widely in their coverage of Armour Thyroid. Most major carriers (Highmark Blue Cross Blue Shield of Delaware, Aetna, Cigna) include Armour Thyroid on their formularies at a Tier 3 or non-preferred brand position.

Tier 3 copays in Delaware typically range from $40 to $75 per month. A 2017 analysis published in Thyroid found that formulary restrictions and step-therapy requirements for thyroid medications increased out-of-pocket costs and reduced medication adherence in hypothyroid patients [8]. Patients with high-deductible health plans (HDHPs) will pay the full cash price until meeting their deductible, making discount programs especially relevant during the first months of the plan year.

For patients on Medicare Part D in Delaware, Armour Thyroid falls into the brand-name drug tier. Under the Inflation Reduction Act provisions effective 2025, the annual out-of-pocket maximum for Part D is capped at $2,000, which limits total thyroid medication costs even without formulary placement [9]. Patients who take multiple brand-name medications may reach this cap through combined spending.

To confirm coverage, patients should call the member services number on their insurance card and request a formulary check using the NDC for their specific Armour Thyroid strength. Prescribers can also run an electronic prior authorization (ePA) through platforms like CoverMyMeds at the point of prescribing.

Allergan Savings Card and Discount Programs

The Allergan savings card for Armour Thyroid can reduce copays for commercially insured patients. Eligible patients may pay as little as $25 per month, depending on their plan structure. The card is not valid for patients covered by government programs, including Medicare, Medicaid, TRICARE, or VA benefits.

Eligibility requirements are straightforward: the patient must have commercial insurance and a valid prescription. Cards can be obtained through the Allergan or AbbVie patient access website or through a prescriber's office. The card typically covers the difference between the patient's copay and the program floor price, up to a maximum annual benefit.

Beyond the manufacturer card, several other discount pathways exist in Delaware. NeedyMeds and RxAssist maintain databases of patient assistance programs that include thyroid medications [10]. The AbbVie Patient Assistance Foundation offers free medication to uninsured patients with household incomes at or below 200% of the federal poverty level. For a single individual in 2026, that threshold is approximately $31,200 annually.

Pharmacy-specific discount clubs (Walmart $4 generic list, Costco member pricing) do not include Armour Thyroid because it is a brand-name product. The compounded NDT route at $40 per month remains the most cost-effective alternative for uninsured patients who cannot access manufacturer assistance.

Telehealth Prescribing of Armour Thyroid in Delaware

Telehealth prescribing of Armour Thyroid is fully permitted in Delaware. State law allows licensed prescribers to evaluate patients and issue prescriptions via synchronous audio-video encounters without requiring an initial in-person visit for thyroid management.

Delaware's telehealth parity law (Title 18, Section 3370) requires commercial insurers to cover telehealth-delivered services at the same rate as in-person visits [11]. This means copays for a telehealth thyroid management visit match in-person rates. Medicaid also covers telehealth visits in Delaware, including for initial hypothyroidism evaluations.

For patients in rural Sussex or Kent County, telehealth eliminates the need to travel to Wilmington or Newark for endocrinology appointments. The prescriber must hold an active Delaware medical license or practice under the Interstate Medical Licensure Compact, to which Delaware is a member state [12].

A practical workflow for telehealth Armour Thyroid prescribing: the patient completes lab work (TSH, free T4, free T3) at a local lab or through a mobile phlebotomy service before the appointment. The prescriber reviews results during the video visit and sends the prescription electronically to the patient's preferred Delaware pharmacy. Follow-up labs are typically drawn 6 to 8 weeks after any dose adjustment, per ATA monitoring recommendations [3].

How to Get the Lowest Price in Delaware

The cheapest path to NDT in Delaware depends on insurance status. Uninsured patients benefit most from compounded NDT at roughly $40 per month through a 503A pharmacy. Commercially insured patients should stack the Allergan savings card on top of their plan benefits, potentially bringing monthly costs to $25.

A step-by-step approach:

1. Check insurance formulary status. Call your insurer or ask your prescriber to run an ePA.
2. Apply the Allergan savings card. If commercially insured, download or request the card before filling.
3. Compare pharmacy cash prices. Use GoodRx or RxSaver to compare prices at Delaware pharmacies. Costco pharmacy (no membership required for prescriptions in Delaware) often has competitive pricing.
4. Consider compounded NDT. If cost is the primary barrier, ask your prescriber about switching to compounded thyroid powder USP from a licensed Delaware 503A pharmacy.
5. Apply for patient assistance. Uninsured patients earning below 200% FPL should contact the AbbVie Patient Assistance Foundation directly.

A 2022 study in JAMA Internal Medicine found that out-of-pocket medication costs exceeding $50 per month were associated with a 24% increase in nonadherence among patients with chronic endocrine conditions [13]. Keeping Armour Thyroid costs below this threshold through the strategies above may directly improve treatment outcomes.

Armour Thyroid Dosing and Monitoring Essentials

Standard starting dose for most adults is 30 mg (0.5 grain) daily, taken on an empty stomach 30 to 60 minutes before breakfast. The ATA 2014 guidelines recommend titrating in 15 mg increments every 4 to 6 weeks based on TSH, free T4, and clinical response [3]. Older adults and patients with cardiovascular disease may start at 15 mg daily.

The target TSH range for most hypothyroid patients on NDT is 0.5 to 2.5 mIU/L, consistent with the National Academy of Clinical Biochemistry (NACB) laboratory guidelines [14]. Free T3 levels should also be monitored because NDT provides direct T3, which can suppress TSH disproportionately to T4 levels. A 2018 meta-analysis in the European Thyroid Journal (12 studies, N=1,216) found no significant difference in cardiovascular adverse events between desiccated thyroid and levothyroxine at equivalent doses [15].

Dose-dependent pricing matters for cost planning: higher grain counts use proportionally larger tablets rather than multiple smaller ones, keeping per-month costs relatively stable across the dose range. A patient on 90 mg (1.5 grains) daily pays roughly the same monthly amount as a patient on 60 mg (1 grain).

Patients should avoid taking Armour Thyroid within 4 hours of calcium supplements, iron supplements, or proton pump inhibitors, as these reduce absorption. The timing of blood draws also matters: labs should be drawn before the morning dose to avoid transient T3 spikes that can falsely lower TSH readings, as described in the Society for Endocrinology position statement on thyroid function testing [16].